Stefania Antonini
Overview
Explore the profile of Stefania Antonini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
777
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brevini T, Pennarossa G, Antonini S, Paffoni A, Tettamanti G, Montemurro T, et al.
Stem Cell Rev Rep
. 2024 Aug;
PMID: 39180682
No abstract available.
2.
Saclier M, Lapi M, Bonfanti C, Rossi G, Antonini S, Messina G
Cells
. 2020 Mar;
9(3).
PMID: 32183151
Macrophages (MPs) are immune cells which are crucial for tissue repair. In skeletal muscle regeneration, pro-inflammatory cells first infiltrate to promote myogenic cell proliferation, then they switch into an anti-inflammatory...
3.
Saclier M, Bonfanti C, Antonini S, Angelini G, Mura G, Zanaglio F, et al.
Cell Death Dis
. 2020 Feb;
11(2):127.
PMID: 32071288
Muscular Dystrophies are severe genetic diseases due to mutations in structural genes, characterized by progressive muscle wasting that compromises patients' mobility and respiratory functions. Literature underlined oxidative stress and inflammation...
4.
Iyer P, Mavoungou L, Ronzoni F, Zemla J, Schmid-Siegert E, Antonini S, et al.
Mol Ther
. 2018 Mar;
26(4):1093-1108.
PMID: 29503200
Duchenne muscular dystrophy (DMD) is a lethal muscle-wasting disease currently without cure. We investigated the use of the PiggyBac transposon for full-length dystrophin expression in murine mesoangioblast (MABs) progenitor cells....
5.
Rossi G, Bonfanti C, Antonini S, Bastoni M, Monteverde S, Innocenzi A, et al.
Nat Commun
. 2017 Oct;
8(1):1055.
PMID: 29057908
Muscular dystrophies are severe disorders due to mutations in structural genes, and are characterized by skeletal muscle wasting, compromised patient mobility, and respiratory functions. Although previous works suggested enhancing regeneration...
6.
Rossi G, Antonini S, Bonfanti C, Monteverde S, Vezzali C, Tajbakhsh S, et al.
Cell Rep
. 2016 Mar;
14(9):2238-2249.
PMID: 26923583
Nfix belongs to a family of four highly conserved proteins that act as transcriptional activators and/or repressors of cellular and viral genes. We previously showed a pivotal role for Nfix...
7.
Bonfanti C, Rossi G, Tedesco F, Giannotta M, Benedetti S, Tonlorenzi R, et al.
Nat Commun
. 2015 Mar;
6:6364.
PMID: 25751651
Mesoangioblasts are vessel-associated progenitor cells that show therapeutic promise for the treatment of muscular dystrophy. Mesoangioblasts have the ability to undergo skeletal muscle differentiation and cross the blood vessel wall...
8.
Brevini T, Pennarossa G, Rahman M, Paffoni A, Antonini S, Ragni G, et al.
Stem Cell Rev Rep
. 2014 May;
10(5):633-42.
PMID: 24858410
Converting adult cells from one cell type to another is a particularly interesting idea for regenerative medicine. Terminally differentiated cells can be induced to de-differentiate in vitro to become multipotent...
9.
Scavone A, Capilupo D, Mazzocchi N, Crespi A, Zoia S, Campostrini G, et al.
Circ Res
. 2013 Jun;
113(4):389-98.
PMID: 23753573
Rationale: A cell-based biological pacemaker is based on the differentiation of stem cells and the selection of a population displaying the molecular and functional properties of native sinoatrial node (SAN)...
10.
Fuoco C, Lavinia Salvatori M, Biondo A, Shapira-Schweitzer K, Santoleri S, Antonini S, et al.
Skelet Muscle
. 2012 Nov;
2(1):24.
PMID: 23181356
Unlabelled: Background: Cell-transplantation therapies have attracted attention as treatments for skeletal-muscle disorders; however, such research has been severely limited by poor cell survival. Tissue engineering offers a potential solution to...